Partnership Bionatus is focused on the improvement of two products that are successful in the Brazilian market
On 22 August 2017, Bionatus announced its partnership with Earth Science Tech, Inc ("ETST"), an innovative biotechnology company operating in the Cannabidiol (CBD) oil segment.

. This partnership is focused on the improvement of two Bionatus products that are successful in the Brazilian market, Propovit spray and Biotoss, to be launched in the USA.
The newest Bionatus division, Laboratoire Bionatus Pharmacognosique Inc. is located in Quebec, Canada, and brings with it the experience acquired along 25 years of success in Brazil.
Like Earth Science Tech, Bionatus and its new division will benefit from the expanding knowledge of pharmaceutical technology that Quebec offers, which provides a fertile ground for the development of even more innovative products.
Dr. Michel Aube, CEO and CSO of ETST:


"We have selected the research center that will conduct the in vitro trials to demonstrate the efficiency of the ETST nutraceuticals, which are based on the company's International Patent Application.
As recently announced, we will soon be supplying the formulations to the Centre De Développement Bioalimentaire Du Québec Inc., (CDBQ) for the conversion of mass forums. Subsequently, the new partner who will test the biological activity of the products will be announced.
We are also finalizing the logistics of launching the long-awaited MSN-2 medical device with its partner, Michel Gauthier, MD. This is expected for the expected product launch in the first quarter of 2018.
Doctors and public health officials from many countries are awaiting the product launch. Recent agreements with the communications agency Absolu, along with Dr. Gauthier's participation, will accelerate these final preparations.

Nickolas S. Tabraue, ETST, president, director and COO, concludes:

"This new partnership offers ETST a new distribution channel, specialised market formulas and remedies for those in need. I personally suffered from asthma as a child and took many pharmaceuticals with side effects to help with the symptoms.
I know that our current CBD oil has helped many with asthma based on many positive comments from customers, but now, thanks to Dr. Michel Aube and the new partnership with Bionatus that he formed, we are now able to formulate a product specifically for asthmatics and offer an alternative to individuals who struggle with asthma as a child.
I look forward to sharing updates on all of Dr. Aube's projects as they progress and on many exciting achievements in our new subsidiary KannaBidioid and product distribution soon".

Source: GlobeNewswire